U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H8Cl2FN3O3S
Molecular Weight 352.169
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZD-1678

SMILES

COC1=C(NS(=O)(=O)C2=C(Cl)C(Cl)=CC=C2)N=CC(F)=N1

InChI

InChIKey=NWSUDJQTTGDPIR-UHFFFAOYSA-N
InChI=1S/C11H8Cl2FN3O3S/c1-20-11-10(15-5-8(14)16-11)17-21(18,19)7-4-2-3-6(12)9(7)13/h2-5H,1H3,(H,15,17)

HIDE SMILES / InChI

Molecular Formula C11H8Cl2FN3O3S
Molecular Weight 352.169
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Tue Apr 01 16:50:04 GMT 2025
Edited
by admin
on Tue Apr 01 16:50:04 GMT 2025
Record UNII
DF5M8SYV7J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD-1678
Code English
2,3-DICHLORO-N-(5-FLUORO-3-METHOXY-PYRAZIN-2-YL)BENZENESULFONAMIDE
Preferred Name English
AZD1678
Code English
2,3-DICHLORO-N-(5-FLUORO-3-METHOXY-2-PYRAZINYL)BENZENESULFONAMIDE
Systematic Name English
BENZENESULFONAMIDE, 2,3-DICHLORO-N-(5-FLUORO-3-METHOXY-2-PYRAZINYL)-
Systematic Name English
Code System Code Type Description
PUBCHEM
23585443
Created by admin on Tue Apr 01 16:50:04 GMT 2025 , Edited by admin on Tue Apr 01 16:50:04 GMT 2025
PRIMARY
FDA UNII
DF5M8SYV7J
Created by admin on Tue Apr 01 16:50:04 GMT 2025 , Edited by admin on Tue Apr 01 16:50:04 GMT 2025
PRIMARY
CAS
942137-41-9
Created by admin on Tue Apr 01 16:50:04 GMT 2025 , Edited by admin on Tue Apr 01 16:50:04 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY
Originator: AstraZeneca; Class: Pyrazine, Small molecule, Sulfonamide; Mechanism of Action: CCR4 receptor antagonist; Highest Development Phase: Preclinical for Allergic asthma; Most Recent Event: 20 Aug 2009 Preclinical trials in Allergic asthma in United Kingdom (unspecified route)